Thursday, December 07, 2017
This column summarizes newly approved drugs and new indications for already approved drugs from February to May 2017. This includes New Drug Applications (NDAs) for small molecules, Biologics Licensing Applications (BLAs), Medical devices and ...
Monday, September 25, 2017
Over the last 20 years, the PDUFA has authorized the USFDA to collect user fees from industry to facilitate the review process for certain human drug applications.
Sunday, November 20, 2016
This column summarizes New Drug Applications (NDAs) approved
in the second quarter 2016 (May-June 2016). In this quarter, FDA
approved 23 NDAs.